$WUXI APPTEC(02359)$ view orde

$WUXI APPTEC(02359)$ view order details.@Trade Feed Decoder

02359

09-08 14:08

HKWUXI APPTEC

Side	Price \| Filled	Realized P&L
Buy Open	116.90 1,200	-- Closed

WUXI APPTEC

Trade Feed: Who is your favorite trader?

Come to the Trade Feed Topic to find more trading opportunities! Also, please feel free to recommend and introduce fellow Tigers to the "hidden gem traders" that you've discovered!

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Trade Feed Decoder
09-08
Trade Feed Decoder
The trade shows a precise entry with a modest +0.43% gain on WUXI APPTEC (02359). While the profit margin appears narrow, it reflects disciplined execution in a volatile sector. The biotech/pharma space often sees sharp moves, making short-term gains notable. The trade’s timing (despite the timestamp anomaly) might align with recent sector-specific catalysts or technical patterns. A 0.43% return could indicate conservative risk management, possibly scaling out of a partial position. Traders might infer a focus on tactical, event-driven opportunities given the sector's sensitivity to regulatory or clinical trial news. However, the minimal gain raises questions about position sizing relative to volatility tolerance. This highlights the importance of aligning profit targets with sector-specific risk profiles.

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":476301187252896,"tweetId":"476301187252896","gmtCreate":1757311951724,"gmtModify":1757389684966,"author":{"id":3583928578091433,"idStr":"3583928578091433","authorId":3583928578091433,"authorIdStr":"3583928578091433","name":"KyrieYang","avatar":"https://community-static.tradeup.com/news/c1cd774bbc2c6182472a3bdb9c2afed8","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":25,"starInvestorFlag":true,"fullDisclosureFlag":true,"starInvestorFollowerNum":25,"starInvestorOrderShareNum":169,"userFollowInvestorFlag":false,"orderNotificationFlag":false,"ror":10.02,"showRor":true,"investmentPhilosophy":"focus on high potential tech stocks","winRationPercentage":48.387097,"tradeVolumeEst":0},"themes":[{"themeId":"4e1ab37448a24dd39b7882426fc6fd27","categoryId":"ab3d937a5fd848c08008411a9be702b5","name":"Trade Feed: Who is your favorite trader?","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":4e1ab37448a24dd39b7882426fc6fd27}&rnconfig={\"headerBarHidden\": true}","description":"Come to the Trade Feed Topic to find more trading opportunities! Also, please feel free to recommend and introduce fellow Tigers to the \"hidden gem traders\" that you've discovered!","image":"https://community-static.tradeup.com/news/e496e574dd744490c7b4f7959f83f5a4"}],"images":[],"coverImages":[],"html":"<html><head></head><body><a href=\"https://ttm.financial/S/02359\">$WUXI APPTEC(02359)$&nbsp;</a>view order details.<a href=\"https://ttm.financial/U/10000000000011061\">@Trade Feed Decoder</a></body></html>","htmlText":"<html><head></head><body><a href=\"https://ttm.financial/S/02359\">$WUXI APPTEC(02359)$&nbsp;</a>view order details.<a href=\"https://ttm.financial/U/10000000000011061\">@Trade Feed Decoder</a></body></html>","text":"$WUXI APPTEC(02359)$ view order details.@Trade Feed Decoder","highlighted":1,"essential":1,"paper":1,"likeSize":19,"commentSize":1,"repostSize":15,"favoriteSize":0,"link":"https://ttm.financial/post/476301187252896","repostId":0,"isVote":1,"tweetType":1,"viewCount":707,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["02359"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":true,"orderData":{"uuid":"3583928578091433","orderId":"40424202602810368","kind":"TRADE","symbol":"02359","secType":"STK","symbolHtmlTag":"<a href=\"https://ttm.financial/S/02359\">$WUXI APPTEC(02359)$&nbsp;</a>","symbolHtmlTagHref":"https://ttm.financial/S/02359","symbolName":"WUXI APPTEC","market":"HK","action":"BUY","currency":"HKD","symbolLogo":"https://static.tigerbbs.com/053e5f0329efa992e7a7c72670889a77","showFilledQuantity":true,"nameCN":"WUXI APPTEC","orderType":"LMT","filledQuantityFinal":1200,"avgFillPrice":116.9,"createTime":1757311690,"filledQuantity":"1200","filledQuantityScale":"0","openFlag":true,"side":"DEBIT","contractMajorDescription":"WUXI APPTEC","contractExtraDescription":"02359","legs":[],"completedFlag":true,"orderPnl":{"openRealizedPnlPercent":0},"quickOrderFlag":false},"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":["订单分享帖","未分享订单分享帖"],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":34,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":476324383338832,"commentId":"476324383338832","gmtCreate":1757317538117,"gmtModify":1757317545526,"authorId":10000000000011060,"author":{"id":10000000000011060,"idStr":"10000000000011061","authorId":10000000000011060,"name":"Trade Feed Decoder","avatar":"https://community-static.tradeup.com/news/4dc8fec78bad5acffbf563bdbc6bc8ed","vip":4,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":476301187252896,"objectIdStr":"476301187252896","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"The trade shows a precise entry with a modest +0.43% gain on WUXI APPTEC (02359). While the profit margin appears narrow, it reflects disciplined execution in a volatile sector. The biotech/pharma space often sees sharp moves, making short-term gains notable. The trade’s timing (despite the timestamp anomaly) might align with recent sector-specific catalysts or technical patterns. A 0.43% return could indicate conservative risk management, possibly scaling out of a partial position. Traders might infer a focus on tactical, event-driven opportunities given the sector's sensitivity to regulatory or clinical trial news. However, the minimal gain raises questions about position sizing relative to volatility tolerance. This highlights the importance of aligning profit targets with sector-specific risk profiles.","text":"The trade shows a precise entry with a modest +0.43% gain on WUXI APPTEC (02359). While the profit margin appears narrow, it reflects disciplined execution in a volatile sector. The biotech/pharma space often sees sharp moves, making short-term gains notable. The trade’s timing (despite the timestamp anomaly) might align with recent sector-specific catalysts or technical patterns. A 0.43% return could indicate conservative risk management, possibly scaling out of a partial position. Traders might infer a focus on tactical, event-driven opportunities given the sector's sensitivity to regulatory or clinical trial news. However, the minimal gain raises questions about position sizing relative to volatility tolerance. This highlights the importance of aligning profit targets with sector-specific risk profiles.","html":"The trade shows a precise entry with a modest +0.43% gain on WUXI APPTEC (02359). While the profit margin appears narrow, it reflects disciplined execution in a volatile sector. The biotech/pharma space often sees sharp moves, making short-term gains notable. The trade’s timing (despite the timestamp anomaly) might align with recent sector-specific catalysts or technical patterns. A 0.43% return could indicate conservative risk management, possibly scaling out of a partial position. Traders might infer a focus on tactical, event-driven opportunities given the sector's sensitivity to regulatory or clinical trial news. However, the minimal gain raises questions about position sizing relative to volatility tolerance. This highlights the importance of aligning profit targets with sector-specific risk profiles.","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerFlag":true,"disclaimerType":1,"specialCommentTag":"AI_ANALYSE"}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/476301187252896"}